This inventor holds 2 USPTO granted patents. Top assignee: Rhone-Poulenc Rorer S.a.. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2000
Title: The Innovations of Jean-Francedillaois Dedieu
Introduction
Jean-Francedillaois Dedieu is a notable inventor based in Paris, France. He has made significant contributions to the field of gene therapy, particularly in the development of recombinant adenoviruses. With a total of 2 patents to his name, Dedieu's work has the potential to impact cancer treatment significantly.
Latest Patents
Dedieu's latest patents include "Cells for the production of recombinant adenoviruses" and "Recombinant adenoviruses for gene therapy in cancers." These innovations are crucial in advancing therapeutic options for patients suffering from various forms of cancer.
Career Highlights
Dedieu is associated with Rhone-Poulenc Rorer S.A., a company known for its research and development in pharmaceuticals. His work at this organization has allowed him to focus on groundbreaking research that aims to improve health outcomes through innovative therapies.
Collaborations
Throughout his career, Dedieu has collaborated with esteemed colleagues such as Michel Perricaudet and Emmanuelle Vigne. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Jean-Francedillaois Dedieu's contributions to the field of gene therapy through his patents and collaborations highlight his role as a significant inventor in the medical research community. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile